policy Archives

Insurance Bob Herman

Supreme Court rules in favor of insurance plan that pushed kidney failure patient to Medicare

Politics Rachel Cohrs

Romney accuses White House of ‘patently false’ information about Covid-19 funds

Politics Lev Facher

Francis Collins on his new life as White House science adviser

Health Andrew Joseph

If Roe is overturned, the ripples could affect IVF and genetic testing of embryos, experts warn

Health Lev Facher

‘Lives could be at stake’: CDC’s Walensky warns of dire stakes surrounding abortion access

Politics Rachel Cohrs

Would drugmakers lower their insulin prices if Congress asks nicely?

Politics Matthew Perrone — Associated Press

FDA issues plan to ban menthol in cigarettes, cigars

Exclusive Lev Facher

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

First Opinion Richard J. Baron and Ezekiel J. Emanuel

Politicians should not be deciding what constitutes good medicine

Politics Lev Facher

In State of the Union, Biden walks a fine line on Covid optimism

Pharmalot Ed Silverman

Judge bars Shkreli from running another public company, fines him $1.4 million

D.C. Diagnosis Nicholas Florko

The new lightning rod in the fight over high drug prices

Politics Lev Facher

Following Lander’s resignation, here’s who might be in line for White House science adviser

Politics Rachel Cohrs

Hospital, physician lobbies sue Biden administration over surprise billing regulation

Politics Rachel Cohrs

Major telehealth players unite ahead of tough lobbying battle

Politics Rachel Cohrs

7 policies in Biden’s spending plan aimed at health equity

Politics Nicholas Florko

Moderate Democrats are still seeking changes to the party’s drug pricing package

First Opinion Stephen Asiimwe, Edith Nakku-Joloba and Aggrey Semeere

Isolated in Uganda: How Covid-19 evacuations highlight unfairness of global health partnerships

Exclusive Rachel Cohrs

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

Politics Lev Facher

Here’s how Biden can address high drug prices, without help from Congress

First Opinion Natalie Ma

My company is developing new antibiotics. My resistant infection showed me we need them now

Politics Rachel Cohrs

Biden abandons his push to lower drug prices

Exclusive Rachel Cohrs and Nicholas Florko

Key Senate committee considers a carveout for small biotech companies in drug pricing reforms

Politics Rachel Cohrs

Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?

Politics Rachel Cohrs and Lev Facher

policy

Most Read

The FDA says it’s in the dark about thousands of dietary supplement ingredients

Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?

Inside the culture of fear in Eric Lander’s White House science office

Tax exemptions for nonprofit hospitals: It’s time taxpayers get their money’s worth

The Trump administration quietly spent billions in hospital funds on Operation Warp Speed

9 ways Covid-19 may forever upend the U.S. health care industry

‘A number of new stars’: The definitive guide to the Trump administration’s coronavirus response team

Tracking Washington’s moves on drug pricing

All Coverage

Supreme Court rules in favor of insurance plan that pushed kidney failure patient to Medicare

Romney accuses White House of ‘patently false’ information about Covid-19 funds

Francis Collins on his new life as White House science adviser

If Roe is overturned, the ripples could affect IVF and genetic testing of embryos, experts warn

‘Lives could be at stake’: CDC’s Walensky warns of dire stakes surrounding abortion access

Would drugmakers lower their insulin prices if Congress asks nicely?

FDA issues plan to ban menthol in cigarettes, cigars

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

Politicians should not be deciding what constitutes good medicine

In State of the Union, Biden walks a fine line on Covid optimism

Judge bars Shkreli from running another public company, fines him $1.4 million

The new lightning rod in the fight over high drug prices

Following Lander’s resignation, here’s who might be in line for White House science adviser

Hospital, physician lobbies sue Biden administration over surprise billing regulation

Major telehealth players unite ahead of tough lobbying battle

7 policies in Biden’s spending plan aimed at health equity

Moderate Democrats are still seeking changes to the party’s drug pricing package

Isolated in Uganda: How Covid-19 evacuations highlight unfairness of global health partnerships

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

Here’s how Biden can address high drug prices, without help from Congress

My company is developing new antibiotics. My resistant infection showed me we need them now

Biden abandons his push to lower drug prices

Key Senate committee considers a carveout for small biotech companies in drug pricing reforms

Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?

In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day